---
title: "MXRX.US (MXRX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MXRX.US/news.md"
symbol: "MXRX.US"
name: "MXRX.US"
parent: "https://longbridge.com/en/quote/MXRX.US.md"
datetime: "2026-03-18T03:53:39.449Z"
locales:
  - [en](https://longbridge.com/en/quote/MXRX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MXRX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MXRX.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/MXRX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/MXRX.US/news.md)


# MXRX.US (MXRX.US) — Related News

### [MedX Seeks Extension to Complete Convertible Note Financing for Teledermatology Expansion](https://longbridge.com/en/news/279292107.md)
*2026-03-16T15:38:02.000Z*
> MedX Seeks Extension to Complete Convertible Note Financing for Teledermatology Expansion

### [Medx Announces Application For Extension Of Non-Brokered Private Placement](https://longbridge.com/en/news/279256825.md)
*2026-03-16T11:37:38.000Z*
### [08:50 ETBoomRx Surpasses $15.5 Million in Net Order Revenue and 77,000+ Processed Orders in First Eight Months](https://longbridge.com/en/news/277790762.md)
*2026-03-04T13:50:36.000Z*
> BoomRx, a leading pharmaceutical technology platform, has achieved over $15.5 million in net order revenue and processed

### [Medexus Pharmaceuticals Releases MD&A Report for Period Ended December 31, 2025](https://longbridge.com/en/news/275669090.md)
*2026-02-11T22:33:22.000Z*
### [MedX Announces Non-Brokered Private Placement Of Series IV Convertible Loan Notes](https://longbridge.com/en/news/274563162.md)
*2026-02-02T22:02:00.000Z*
### [First Berlin Equity Research Initiates MedX Health Coverage With CAD 0.28 Price Target](https://longbridge.com/en/news/273998521.md)
*2026-01-28T13:45:26.000Z*